Reducing Risk in the Treatment of Attention-Deficit/Hyperactivity Disorder Among Adults With Comorbidities
Journal of Psychosocial Nursing and Mental Health Services
|January 4, 2024
Summary
Recent attention-deficit/hyperactivity disorder (ADHD) medication shortages may signal increased awareness and treatment seeking. Effective adult ADHD management requires integrated care for co-occurring conditions, improving overall functioning.
Area of Science:
- Neuroscience
- Psychiatry
- Public Health
Background:
- Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, often diagnosed in childhood.
- Adult ADHD symptoms may present differently, with inattention, impulsivity, and emotional dysregulation being more prominent than hyperactivity.
- Recent medication shortages highlight increased public awareness, help-seeking, and treatment for ADHD.
Purpose of the Study:
- To discuss the clinical evaluation and treatment of adult ADHD.
- To emphasize the importance of differentiating ADHD from comorbid conditions in adults.
- To review integrated treatment approaches for adult ADHD and co-occurring disorders.
Main Methods:
- Literature review of ADHD diagnosis and treatment guidelines.
- Analysis of clinical presentation in adults with and without childhood diagnoses.
- Discussion of integrated care models for managing ADHD and comorbidities.
Main Results:
- Adult ADHD diagnosis requires corroborating childhood symptoms and differentiating from other psychiatric disorders.
- Integrated treatment addressing both ADHD and comorbid conditions can improve functioning.
- Prioritizing the most impairing disorder in integrated care is recommended.
Conclusions:
- Adult ADHD is a significant clinical concern requiring careful diagnosis and management.
- Integrated treatment approaches are crucial for optimizing outcomes in adults with ADHD and comorbidities.
- Addressing ADHD and co-occurring disorders holistically improves patient functioning and quality of life.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.8K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
10.3K
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
68
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
68
01:28Drug Therapy
45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
45
01:26Modeling in Therapy
84
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
84
01:23Antidepressant Drugs: MAOIs and Other Agents
239
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
239
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
127
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
127